GB1264197A - - Google Patents
Info
- Publication number
- GB1264197A GB1264197A GB1264197DA GB1264197A GB 1264197 A GB1264197 A GB 1264197A GB 1264197D A GB1264197D A GB 1264197DA GB 1264197 A GB1264197 A GB 1264197A
- Authority
- GB
- United Kingdom
- Prior art keywords
- salts
- esters
- compositions
- hypolipemic
- inflammatory
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR696919339A FR2047876B1 (nl) | 1969-06-11 | 1969-06-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1264197A true GB1264197A (nl) | 1972-02-16 |
Family
ID=9035547
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB1264197D Expired GB1264197A (nl) | 1969-06-11 | 1969-07-18 |
Country Status (11)
Country | Link |
---|---|
BE (1) | BE736219A (nl) |
BR (1) | BR6910855D0 (nl) |
CA (1) | CA943545A (nl) |
CH (1) | CH513909A (nl) |
DE (1) | DE1966948C2 (nl) |
DK (1) | DK140256B (nl) |
ES (1) | ES369646A1 (nl) |
FR (1) | FR2047876B1 (nl) |
GB (1) | GB1264197A (nl) |
IL (1) | IL32616A (nl) |
NL (1) | NL157801B (nl) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2228483A2 (en) * | 1973-05-11 | 1974-12-06 | Roussel Uclaf | Esters and salts of 2-propylthiazole-5-carboxylic acid - vasodilators and hypolipidaemics |
FR2289189A1 (fr) * | 1974-10-29 | 1976-05-28 | Roussel Uclaf | Nouveaux derives d'acides 2-hydroxyalkyl thiazol 5-carboxyliques, leur procede de preparation et leur application comme medicaments |
-
1969
- 1969-06-11 FR FR696919339A patent/FR2047876B1/fr not_active Expired
- 1969-07-14 IL IL32616A patent/IL32616A/xx unknown
- 1969-07-16 CA CA057,213*7A patent/CA943545A/en not_active Expired
- 1969-07-17 BE BE736219D patent/BE736219A/xx not_active IP Right Cessation
- 1969-07-17 ES ES369646A patent/ES369646A1/es not_active Expired
- 1969-07-17 DK DK387269AA patent/DK140256B/da not_active IP Right Cessation
- 1969-07-17 CH CH1095569A patent/CH513909A/fr not_active IP Right Cessation
- 1969-07-18 GB GB1264197D patent/GB1264197A/en not_active Expired
- 1969-07-18 BR BR210855/69A patent/BR6910855D0/pt unknown
- 1969-07-18 NL NL6911060.A patent/NL157801B/nl not_active IP Right Cessation
- 1969-07-18 DE DE1966948A patent/DE1966948C2/de not_active Expired
Also Published As
Publication number | Publication date |
---|---|
IL32616A0 (en) | 1969-09-25 |
DE1966948C2 (de) | 1983-04-21 |
FR2047876B1 (nl) | 1973-03-16 |
DK140256B (da) | 1979-07-16 |
CA943545A (en) | 1974-03-12 |
BE736219A (nl) | 1970-01-19 |
DE1966948A1 (de) | 1975-07-24 |
FR2047876A1 (nl) | 1971-03-19 |
CH513909A (fr) | 1971-10-15 |
BR6910855D0 (pt) | 1973-05-10 |
ES369646A1 (es) | 1971-06-01 |
DK140256C (nl) | 1979-12-17 |
IL32616A (en) | 1974-03-14 |
NL6911060A (nl) | 1970-12-15 |
NL157801B (nl) | 1978-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB1413519A (en) | Isothiocyanaobenzazoles and process for their production | |
GB1181673A (en) | Derivatives of Xanthen and Thiaxanthen and Preparation Thereof | |
GB1355147A (en) | Oxoprostanoic acid derivatives | |
GB1265279A (nl) | ||
GB1496491A (en) | Dihydroergopeptine derivatives | |
GB1264197A (nl) | ||
GB1262292A (en) | Novel thiazoline derivatives, the preparation thereof and compositions containing the same | |
GB1261989A (en) | 5-thiazolecarboxylic acid derivatives, their preparation and pharmaceutical compositions containing the same | |
GB1225461A (nl) | ||
GB1421589A (en) | Salicylanilide derivatives | |
GB1188364A (en) | Quinoline Derivatives | |
SE300011B (nl) | ||
ES481855A1 (es) | Procedimiento para la preparacion de nuevos revidados de 6- metoxi-2-acetilnaftaleno oxima con actividad analgesica. | |
GB1448758A (en) | Thiazole derivatives | |
GB1400851A (en) | Triidothyroalkyl compounds their method of preparation and therapeutical compositions containing such compounds | |
GB1352392A (en) | Phenylisopropylamine derivatives | |
GB1195319A (en) | Alkyl Sulfate Salts of 1-(p-Chlorobenzhydryl)-4-Methylhomopiperazines | |
GB1227189A (nl) | ||
GB1437788A (en) | Therapeutic compositions | |
GB1164562A (en) | Novel Esters derived from 5-Nitro Quinaldine | |
GB1338124A (en) | Phenothiazine derivatives | |
GB1228080A (nl) | ||
GB1434645A (en) | Tetrazole coumarin derivatives | |
GB1457950A (en) | Antibacterial compositions | |
GB1284516A (en) | Aminopropionyl derivatives of 2,3-diphenyl-cyclopropylamine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PS | Patent sealed [section 19, patents act 1949] | ||
PCNP | Patent ceased through non-payment of renewal fee |